Aquatic Capital Management LLC Exelixis, Inc. Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$19.04 - $22.74 $807,296 - $964,175
42,400 New
42,400 $926,000
Q1 2023

May 15, 2023
BUY
$16.3 - $19.41 $332,520 - $395,964
20,400 New
20,400 $396,000
Q3 2022

Nov 14, 2022
BUY
$15.68 - $22.27 $798,112 - $1.13 Million
50,900 Added 385.61%
64,100 $1.01 Million
Q2 2022

Aug 15, 2022
BUY
$17.44 - $23.16 $230,208 - $305,712
13,200 New
13,200 $275,000

Others Institutions Holding EXEL

# of Institutions
507
Shares Held
243M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email